EE200200374A - Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemia - Google Patents
Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemiaInfo
- Publication number
- EE200200374A EE200200374A EEP200200374A EEP200200374A EE200200374A EE 200200374 A EE200200374 A EE 200200374A EE P200200374 A EEP200200374 A EE P200200374A EE P200200374 A EEP200200374 A EE P200200374A EE 200200374 A EE200200374 A EE 200200374A
- Authority
- EE
- Estonia
- Prior art keywords
- enoxaparin
- medicament
- manufacture
- treatment
- cerebral ischemia
- Prior art date
Links
- 201000006474 Brain Ischemia Diseases 0.000 title 1
- 206010008120 Cerebral ischaemia Diseases 0.000 title 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title 1
- 206010008118 cerebral infarction Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229960000610 enoxaparin Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0000137A FR2803522B1 (en) | 2000-01-06 | 2000-01-06 | NEW THERAPEUTIC APPLICATION OF ENOXAPARIN |
| PCT/FR2001/000014 WO2001049298A2 (en) | 2000-01-06 | 2001-01-03 | Novel therapeutic use of enoxaparin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200374A true EE200200374A (en) | 2003-12-15 |
Family
ID=8845669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200374A EE200200374A (en) | 2000-01-06 | 2001-01-03 | Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemia |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1248638B1 (en) |
| JP (1) | JP2003519185A (en) |
| KR (1) | KR20020069240A (en) |
| CN (1) | CN1400905A (en) |
| AR (1) | AR026804A1 (en) |
| AT (1) | ATE344671T1 (en) |
| AU (1) | AU784656B2 (en) |
| BR (1) | BR0107442A (en) |
| CA (1) | CA2396178A1 (en) |
| CZ (1) | CZ20022303A3 (en) |
| DE (1) | DE60124373T2 (en) |
| DK (1) | DK1248638T3 (en) |
| EA (1) | EA006035B1 (en) |
| EE (1) | EE200200374A (en) |
| ES (1) | ES2275648T3 (en) |
| FR (1) | FR2803522B1 (en) |
| HK (1) | HK1052649A1 (en) |
| HR (1) | HRP20020573A2 (en) |
| HU (1) | HUP0204040A3 (en) |
| IL (1) | IL150477A0 (en) |
| MX (1) | MXPA02006672A (en) |
| NO (1) | NO20023243L (en) |
| NZ (1) | NZ520283A (en) |
| PL (1) | PL357192A1 (en) |
| PT (1) | PT1248638E (en) |
| SK (1) | SK9612002A3 (en) |
| UA (1) | UA75587C2 (en) |
| WO (1) | WO2001049298A2 (en) |
| YU (1) | YU51802A (en) |
| ZA (1) | ZA200205415B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2231358C2 (en) * | 2002-06-11 | 2004-06-27 | Научно-исследовательский институт кардиологии Томского научного центра СО РАМН | Method of treating acute coronary syndrome without raising segment |
| AR063530A1 (en) * | 2006-10-30 | 2009-01-28 | Aventis Pharma Sa | PROCEDURE FOR THE USE OF SODIUM ENOXAPARINE FOR THE PREPARATION OF A MEDICINAL PRODUCT |
| ITMI20091445A1 (en) * | 2009-08-07 | 2011-02-08 | Inalco S P A A Socio Unico | SEMI-SYNTHETIC DERIVATIVES OF K5 POLISACCARIDE FOR THE PREVENTION AND TREATMENT OF TISSUE DAMAGE ASSOCIATED WITH ISCHEMIA AND / OR REPERFUSION |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5442594A (en) * | 1992-10-13 | 1994-05-09 | Virginia Commonwealth University | Use of non-anticoagulant heparin for treating ischemia/reperfusion injury |
| US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
-
2000
- 2000-01-06 FR FR0000137A patent/FR2803522B1/en not_active Expired - Fee Related
-
2001
- 2001-01-03 DE DE60124373T patent/DE60124373T2/en not_active Expired - Fee Related
- 2001-01-03 CN CN01803471A patent/CN1400905A/en active Pending
- 2001-01-03 HK HK03104944.6A patent/HK1052649A1/en unknown
- 2001-01-03 MX MXPA02006672A patent/MXPA02006672A/en active IP Right Grant
- 2001-01-03 WO PCT/FR2001/000014 patent/WO2001049298A2/en not_active Ceased
- 2001-01-03 KR KR1020027008754A patent/KR20020069240A/en not_active Ceased
- 2001-01-03 DK DK01903859T patent/DK1248638T3/en active
- 2001-01-03 ES ES01903859T patent/ES2275648T3/en not_active Expired - Lifetime
- 2001-01-03 AU AU31830/01A patent/AU784656B2/en not_active Ceased
- 2001-01-03 CZ CZ20022303A patent/CZ20022303A3/en unknown
- 2001-01-03 BR BR0107442-3A patent/BR0107442A/en not_active IP Right Cessation
- 2001-01-03 NZ NZ520283A patent/NZ520283A/en unknown
- 2001-01-03 YU YU51802A patent/YU51802A/en unknown
- 2001-01-03 EA EA200200750A patent/EA006035B1/en not_active IP Right Cessation
- 2001-01-03 EP EP01903859A patent/EP1248638B1/en not_active Expired - Lifetime
- 2001-01-03 CA CA002396178A patent/CA2396178A1/en not_active Abandoned
- 2001-01-03 HR HR20020573A patent/HRP20020573A2/en not_active Application Discontinuation
- 2001-01-03 PT PT01903859T patent/PT1248638E/en unknown
- 2001-01-03 EE EEP200200374A patent/EE200200374A/en unknown
- 2001-01-03 JP JP2001549666A patent/JP2003519185A/en active Pending
- 2001-01-03 SK SK961-2002A patent/SK9612002A3/en not_active Application Discontinuation
- 2001-01-03 HU HU0204040A patent/HUP0204040A3/en unknown
- 2001-01-03 PL PL01357192A patent/PL357192A1/en unknown
- 2001-01-03 AT AT01903859T patent/ATE344671T1/en not_active IP Right Cessation
- 2001-01-03 IL IL15047701A patent/IL150477A0/en unknown
- 2001-01-05 AR ARP010100054A patent/AR026804A1/en unknown
- 2001-03-01 UA UA2002076399A patent/UA75587C2/en unknown
-
2002
- 2002-07-04 NO NO20023243A patent/NO20023243L/en not_active Application Discontinuation
- 2002-07-05 ZA ZA200205415A patent/ZA200205415B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2020007I1 (en) | Sitagliptin, optionally in the form of a pharmaceutically acceptable salt | |
| NO20034388D0 (en) | Therapeutic agent for chronic arthritis diseases in child-related diseases | |
| IL183506A (en) | Use of a compound in the manufacture of a medicament for treating a neoplastic disease | |
| IL168279A (en) | Use of liposomal aminoglycoside formulation in the manufacture of a medicament for treating or ameliorating pulmonary infection | |
| IL183101A (en) | Use of tetrahydrocannabivarin in the manufacture of medicaments | |
| DE60103621D1 (en) | CROSSLINKABLE OR POLYMERIZABLE PREPOLYMERS | |
| EP1296697A4 (en) | THERAPEUTIC AGENTS - I | |
| PT1294682E (en) | A process for the preparation and the use as a medicament | |
| AR028622A1 (en) | USEFUL TROPANO DERIVATIVES IN THERAPY | |
| PT1485127E (en) | ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION | |
| DE10192161T1 (en) | Medical guidewire | |
| MXPA03005731A (en) | Absorbent article having releasable medicinal treatments. | |
| IS6891A (en) | Methods for administering epothilone analogues to treatment cancer | |
| AR027945A1 (en) | USE OF PRAMIPEXOL IN THE TREATMENT OF ADDICTION DISORDERS | |
| EE200200214A (en) | Use of dipyridamole or mopidamol in the manufacture of a medicament for the prevention and treatment of fibrin dependent microcirculation disorders | |
| EE05056B1 (en) | Use of IL-18 inhibitors in the manufacture of a medicament for the treatment and / or prevention of atherosclerosis | |
| PT1248608E (en) | SUBSTANCES FOR USE IN PSORIASIS TREATMENT | |
| IL170309A (en) | Use of chondroitin sulfate in the preparation of a medicament for cystitis treatment | |
| EP1757282A4 (en) | The use of kauranes compounds in the manufacture of medicament | |
| DE60222664D1 (en) | SKIN TREATMENT AGENT | |
| NO20050689L (en) | Therapeutic use | |
| EE200200374A (en) | Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemia | |
| IL160781A0 (en) | Use of lh in the manufacture of a medicament | |
| NO20032006L (en) | Use of melagatran for the manufacture of a medicament for the treatment of ischemic disorders | |
| EP1709962A4 (en) | The use of l-butylphthalide in the manufacturing of medicines for the prevention and treatment of cerebral ischemia disease |